Periodontitis as a risk factor for cardiovascular disease: the role of anti-phosphorylcholine and anti-cardiolipin antibodies

scientific article published on July 2008

Periodontitis as a risk factor for cardiovascular disease: the role of anti-phosphorylcholine and anti-cardiolipin antibodies is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P932PMC publication ID2504402
P698PubMed publication ID18923669

P2093author name stringA Vakaloudi
K Karnoutsos
P Papastergiou
S Stefanidis
P2860cites workStreptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factorQ28289854
Dominant cross-reactive antibodies generated during the response to a variety of oral bacterial species detect phosphorylcholineQ28370788
The pathogenesis of atherosclerosis: a perspective for the 1990sQ29547827
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy menQ29619308
Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndromeQ33341518
Dental plaque, platelets, and cardiovascular diseasesQ33503491
Interleukin-1 gene expression in rabbit vascular tissue in vivo.Q33528100
Phosphorylcholine-dependent cross-reactivity between dental plaque bacteria and oxidized low-density lipoproteinsQ33551868
Invasion of human vascular endothelial cells by Actinobacillus actinomycetemcomitans via the receptor for platelet-activating factorQ33600465
Helicobacter pylori: from the stomach to the heartQ33774677
PeriodontitisQ33947962
Cardiolipin and apoptosisQ33963761
Antiphosphorylcholine antibody levels are elevated in humans with periodontal diseases.Q34001859
Global epidemiology of periodontal diseases in children and young personsQ34137416
Opsonization of Actinobacillus actinomycetemcomitans by immunoglobulin G antibody reactive with phosphorylcholineQ34184251
Periodontal infections and cardiovascular disease--how strong is the association?Q34252421
Overexpression of the obese (ob) gene in adipose tissue of human obese subjectsQ34297440
Periodontal diseases in the United States populationQ34462578
Cytomegalovirus DNA in arterial walls of patients with atherosclerosisQ63983747
Interleukin-1 beta and tumor necrosis factor-alpha release in normal and diseased human infrarenal aortasQ67581316
Cross-reactive immunodeterminants on Streptococcus sanguis and collagen. Predicting a structural motif of platelet-interactive domainsQ67896400
Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactorQ68090535
A collagen-like immunodeterminant on the surface of Streptococcus sanguis induces platelet aggregationQ68991811
Dental infections in association with cerebral infarction in young and middle-aged menQ69581412
Inhibition of murine B cell proliferation and down-regulation of protein kinase C levels by a phosphorylcholine-containing filarial excretory-secretory productQ70504104
The Streptococcus sanguis platelet aggregation-associated protein. Identification and characterization of the minimal platelet-interactive domainQ70531221
Viridans streptococcal shock in bone marrow transplantation patientsQ70717412
Evidence of type 2 herpes simplex infection in human coronary arteries at the time of coronary artery bypass surgeryQ70839924
The use of an anti-beta 2-glycoprotein-I assay for discrimination between anticardiolipin antibodies associated with infection and increased risk of thrombosisQ70862020
Does atherosclerosis have an infectious etiology?Q71493511
Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention TrialQ71512983
The pathogenesis of atherosclerosisQ71550913
Therapeutic advantage of recombinant human plasminogen activator in endocarditis: evidence from experiments in rabbitsQ71575947
Effects of oral flora on platelets: possible consequences in cardiovascular diseaseQ71763800
In Vitro Plaque-Forming Cell Responses Induced by Streptococcus pneumoniae in HumansQ72726470
Teichoic acid and lipoteichoic acid of Streptococcus pneumoniae possess identical chain structures. A reinvestigation of teichoid acid (C polysaccharide)Q72886719
Specificity of anti-phospholipid antibodies in infectious mononucleosis: a role for anti-cofactor protein antibodiesQ73738644
Oral health and systemic disease: periodontitis and cardiovascular diseaseQ77663137
The antiphospholipid syndromeQ77739053
Atherosclerotic plaque formation and risk factorsQ35063770
Social influences and cardiovascular risk factors as determinants of plasma fibrinogen concentration in a general population sample of middle aged men.Q35168292
Dental disease and risk of coronary heart disease and mortalityQ35187117
Lipids and atherosclerosis.Q35723517
Beta-2-glycoprotein-I, infections, antiphospholipid syndrome and therapeutic considerationsQ35829217
Antiphospholipid syndrome associated with infections: clinical and microbiological characteristicsQ36329966
The pathogenesis of coronary artery disease and the acute coronary syndromes (1).Q36728740
The pathogenesis of coronary artery disease and the acute coronary syndromes (2).Q36730913
Infection as a risk factor for infarction and atherosclerosisQ36845622
The platelet interactivity phenotype of Streptococcus sanguis influences the course of experimental endocarditisQ36971198
Phenotypic characterization of Streptococcus sanguis virulence factors associated with bacterial endocarditis.Q36977250
Potential role of viruses in thrombosis and atherosclerosisQ37828201
Multiple infections in carotid atherosclerotic plaquesQ37877522
Infective endocarditis due to unusual or fastidious microorganismsQ37882767
Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular diseaseQ37884972
Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factorsQ37886448
Infection and inflammation as risk factors for myocardial infarctionQ37889945
Diagnosis and classification of the periodontal diseases.Q39645300
Fibrinogen and cardiovascular risk.Q40429656
Critical issues in periodontal researchQ40545603
Beta 2-glycoprotein I.Q40558449
Aggregation of human platelets and adhesion of Streptococcus sanguisQ40600571
Platelet-streptococcal interactions in endocarditisQ40674375
High-dose cytosine arabinoside and viridans streptococcus sepsis in children with leukemiaQ40683205
Alpha-hemolytic streptococcal bacteremia: a review of 203 episodes during 1980-1991.Q40783941
Vascular transcellular signaling.Q40811205
Fibrinogen: its role in the hemostatic regulation in atherosclerosisQ40837683
NHLBI Family Heart Study: objectives and designQ40936323
Do non-insulin-dependent diabetes mellitus and cardiovascular disease share common antecedents?Q40941532
Links between hypertension and myocardial infarctionQ41013646
Thrombosis in ischemic heart diseaseQ41014378
Genetics and cholesterol metabolismQ41119438
Periodontal diseases: pathogenesisQ41444984
PAf receptor anchors Streptococcus pneumoniae to activated human endothelial cellsQ41455460
Lipopolysaccharide stimulation of RAW 264.7 macrophages induces lipid accumulation and foam cell formationQ41579091
The host response to the microbial challenge in periodontitis: assembling the playersQ41754952
Cigarette Smoking Acutely Increases Platelet Thrombus Formation in Patients With Coronary Artery Disease Taking AspirinQ42276632
A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarctionQ43603017
Prevalence of medical problems in periodontal patients obtained from three different populationsQ43637621
Antiphospholipid antibodies induced in mice by immunization with a cytomegalovirus-derived peptide cause thrombosis and activation of endothelial cells in vivoQ43882937
Platelet activation by emotional stress in patients with coronary artery disease.Q43980274
Anticardiolipin antibodies in infections are heterogenous in their dependency on beta 2-glycoprotein I: analysis of anticardiolipin antibodies in leprosyQ44184972
The autoreactivity of anti-phosphorylcholine antibodies for atherosclerosis-associated neo-antigens and apoptotic cellsQ44470214
Anti-cardiolipin antibodies in sera from patients with periodontitisQ44898311
Anti-cardiolipin and increased serum adhesion molecule levels in patients with aggressive periodontitisQ44927548
Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunitiesQ48501090
Host responses in patients with generalized refractory periodontitis.Q50153570
Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis.Q51012002
A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis.Q51037257
Systemic diseases in elderly dental patients.Q51663237
The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress.Q52046994
Receptor specificity of adherence of Streptococcus pneumoniae to human type-II pneumocytes and vascular endothelial cells in vitro.Q54785298
Prevention of Infective EndocarditisQ56656308
P433issue3
P921main subjectcardiovascular diseaseQ389735
periodontitisQ520127
risk factorQ1475848
P304page(s)144-149
P577publication date2008-07-01
P1433published inHippokratiaQ26842167
P1476titlePeriodontitis as a risk factor for cardiovascular disease: the role of anti-phosphorylcholine and anti-cardiolipin antibodies
P478volume12